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In ~ 706) (n = 75) PValue
Successful PTCA 664194.1%) 74(98.1%) 0.16
Lab Death 811.1%) 2 (2.7%) 0.24
Hospital Mortality 36(5.1%) 16(21.3%) 000001
Reinfarction 32 (4.6%) 7(9.5%) 0.11
Recurrent Ischemia 19(2.7%) 4(5.3%) 040
Stroke 4(0.6%) 415.3%) 0.004
*: P < 0.05, MLO: minimal lumen diameter
Conclusion: 1) PS stent implantation can be performed in elderly pts with
the acceptable complications. 2) But stent delivery is more difficult because
of complex lesions, especially lesions containing calcium, and major com-
plications tend to occur more frequent. 3) Long-term efficacy is similar to
younger pts.
Balloon PTCA in elderly patients (pts) has been associated with diminished
clinical success rates, due to the presence of unfavorable patient and lesion
characteristics. To assess whether Palmaz-Schatz (PS) stent is a useful alter-
native to balloon PTCA in elderly(~75 years old) pts, immediate and follow-up
(FU) results were analyzed in 331 patients ~ 65 years old and compared pts
~ 75 years old with those 65 to 74 years old. Clinical success was defined as
<50% residual stenosis without death, CABG, Q-wave MI. FU quantitative
angiography was obtained from 176 patients after 6 months or earlier when
indicated by symptoms. Clinical FU data was obtained after 6-12 months.
Event-free survival was defined as free from death, MI, CABG, target lesion
PTCA at FU.
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Efficacy and Safety of Palmaz-Schatz Stent in Elderly
(2:75 Years Old) Patients: Early and Follow-up
Results
Hiroyoshi Yokoi, Takeshi Kimura, Yoshihiro Sawada, Hideyuki Nosaka,
Masakiyo Nobuyoshi. Kokura Memorial Hospital, Kitakyushu, Japan
Reperfusion therapy has been expanded to include elderly pts (EL). and pri-
mary angioplasty (PTCA) has been promoted as a preferable alternative to
thrombolytic therapy (TI) for acute myocardial infarction (AMI) in the elderly
(EL). The purpose of this study was to compare outcomes of EL and non-EL
pts considered eligible to receive TI who received PTCA for AMI. Patients
with cardiogenic shock, prior bypass, and reperfusion time> 12 hrs were
considered ineligible for TI. Of 781 consecutively treated pts eligible for TI,
75 (9.6%) were ~75 yrs, and 706 (90.4%) were <75 yrs. EL were more likely
to be women (50.7 vs 25.1 %, P < 0.0001). have prior AMI (32 vs 18.1 %, P
< 0.01). and to have anterior infarction (64 vs 40.1 %, P < 0.0001). Baseline
ejection fraction and reperfusion time were similar in both groups. Outcomes
are listed below.
For pts <65 yrs (n = 522) compared to ~65 yrs (n = 259). hospital mortality
was 3.4% vs 13.1 %, P < 0.0001.
Conclusion: Despite a high rate of successful reperfusion, PTCA in elderly
n candidates is associated with considerable mortality and morbidity. Fur-
ther study is needed to establish the best option for the elderly.
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Primary Angioplasty for Acute Myocardial Infarction
in Elderly Thrombolytic Candidates: Is It the Best
Option?
Thomas Stuckey, Bruce Brodie, Charles Hansen, Denise Muncy,
Richard Weintraub, Thomas Kelly, Jonathan Berry, E. Joseph LeBauer. The Moses H.
Cone Memorial Hospital, Greensboro, N. C.
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Long-term Outcome in Patients with Negative Stress
SPECT Scintigraphy Following PTCA
Patient group LOS In-hospital 1 year 3 year
mortality mortality mortality
All patients >80 4 7.0%* 17.0%* 29.6%*
AMI >80 15.8%* 24.6%* 35.0%*
All patients 65--69 1.8%* 5.2%* 10.4%*
U.S. Population age 82 7.7% 23.6%
The use of coronary angioplasty (PTCA) in the very elderly has undergone ex-
plosive growth. Using the Medicare Provider Analysis and Review (MEDPARj
file from 1987 through 1990, we examined PTCA for all patients greater than
80 years old. The demographics of these patients included mean age 82.6
(range 80-100, 1st Quartile 81, Median 82, 3rd Quartile 84). 45% women,
3.9% non-white, 25.2% involving acute myocardial infarction admissions
(AMI). 25.4% having Charlson comorbidity index 1 or greater. The annual
number of patients over age 80 undergoing PTCA more than doubled over
the course of the study: 1987-3082,1988-4284, 1989-5369, 1990-7341. Short
and intermediate term outcomes of these patients are listed below:
*99% confidence intervals within 0.2%
LOS ~ median length of stay after PTCA in days
Patients over age 80 had significantly higher in-hospital and intermediate-
term mortality following PTCA compared to 65-69 year old patients in the
MEDPAR file. However, their survival at 3 years was comparable to survival
for the age-matched general United States (U.S.) population. This study is
the largest reported series of PTCA in very elderly patients, and includes the
majority of patients over age 80 treated in the U.S. during the study period.
With the growth of the elderly population and the increased use of PTCA
in these very elderly patients, information concerning their outcomes are
important in guiding treatment decisions.
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Many patients who have had successful PTCA are presumed to be at in-
creased long-term risk for subsequent cardiac events, based on the focused
nature of their revascularization and the frequent presence of mild-moderate
residual CAD. The purpose of this investigation was to determine long-term
prognosis in patients with a nonischemic stress SPECT scintigraphic test af-
ter PTCA. Between 1988 and 1993,425 patients had stress SPECT scintigra-
phy performed between 3 months and 2 years after PTCA(mean 9.2 months).
and showed no reversible perfusion defects. Mean age was 61 years, 277
were male, 62 had prior CABG, 183 had prior infarction, and 171 were symp-
tomatic with typical or atypical angina. Three hundred eleven (73%) tests
were performed with exercise and 114 pharmacologically (adenosine = 96;
dipyridamole = 18). Eight pts (2%) were lost to follow-up.
Of the remaining 417 pts, there were 62 events over a mean follow-up of 30
months: cardiac death = 1; non-fatal MI ~ 5; PTCA/CABG = 56. Mean time
from a nonischemic SPECT scan until any event was 20 months. Freedom
from death or MI was 99% at 1 yr; 99% at 2 yrs; 98% at 3 yrs; and 97% at
4 yrs. Freedom from any cardiac event was 93% at 1 yr; 89% at 2 yrs; 84%
at 3 yrs; and 81 % at 4 yrs.
This study establishes that pts who have a nonischemic SPECT scan be-
yond the third month after PTCA have an excellent long-term prognosis with
a very low likelihood of death or MI. Such pts may however be at higher risk
for subsequent revascularization than the initial negative post-PTCA SPECT
scan might otherwise imply.
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Coronary Angioplasty in 20,006 Patients Over Age 80
in the United States
James G. Jollis, Eric D. Peterson, Judith D. Bebchuk, Elizabeth R. DeLong, J.
O'Neal Humphries, Lawrence H. Muhlbaier, David B. Pryor, Daniel B. Mark. Duke
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